190 related articles for article (PubMed ID: 15371950)
61. "Dissecting Gonadoblastoma" of Scully: A Morphologic Variant That Often Mimics Germinoma.
Kao CS; Idrees MT; Young RH; Ulbright TM
Am J Surg Pathol; 2016 Oct; 40(10):1417-23. PubMed ID: 27454939
[TBL] [Abstract][Full Text] [Related]
62. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis.
Cossu-Rocca P; Zhang S; Roth LM; Eble JN; Zheng W; Karim FW; Michael H; Emerson RE; Jones TD; Hattab EM; Cheng L
Mod Pathol; 2006 Apr; 19(4):611-5. PubMed ID: 16554737
[TBL] [Abstract][Full Text] [Related]
63. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
[TBL] [Abstract][Full Text] [Related]
64. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases.
Gupta D; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2004 Jun; 28(6):771-80. PubMed ID: 15166669
[TBL] [Abstract][Full Text] [Related]
65. Human chorionic gonadotropin-secreting pure dysgerminoma.
Zarabi MC; Rupani M
Hum Pathol; 1984 Jun; 15(6):589-92. PubMed ID: 6724577
[TBL] [Abstract][Full Text] [Related]
66. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
[TBL] [Abstract][Full Text] [Related]
67. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival.
Kwon AY; Heo I; Lee HJ; Kim G; Kang H; Heo JH; Kim TH; An HJ
Virchows Arch; 2016 May; 468(5):597-605. PubMed ID: 26951260
[TBL] [Abstract][Full Text] [Related]
68. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
[TBL] [Abstract][Full Text] [Related]
70. Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?
Howell NR; Zheng W; Cheng L; Tornos C; Kane P; Pearl M; Chalas E; Liang SX
Int J Gynecol Pathol; 2007 Apr; 26(2):134-40. PubMed ID: 17413979
[TBL] [Abstract][Full Text] [Related]
71. Histochemistry of hormonally active ovarian tumors.
Kedzia H; Pisarski T
Pol Med Sci Hist Bull (1973); 1975; 15(2):229-39. PubMed ID: 177958
[TBL] [Abstract][Full Text] [Related]
72. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
Baker PM; Oliva E; Young RH; Talerman A; Scully RE
Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
[TBL] [Abstract][Full Text] [Related]
73. Transformation of ovarian dysgerminoma to yolk sac tumor: evidence for a histogenetic continuum.
Parkash V; Carcangiu ML
Mod Pathol; 1995 Oct; 8(8):881-7. PubMed ID: 8552580
[TBL] [Abstract][Full Text] [Related]
74. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
75. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
76. Canine ovarian neoplasms: a clinicopathologic study of 71 cases, including histology of 12 granulosa cell tumors.
Patnaik AK; Greenlee PG
Vet Pathol; 1987 Nov; 24(6):509-14. PubMed ID: 2842918
[TBL] [Abstract][Full Text] [Related]
77. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
Chou YY; Jeng YM; Kao HL; Chen T; Mao TL; Lin MC
Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
[TBL] [Abstract][Full Text] [Related]
78. Ovarian sex cord-stromal tumours and their mimics.
Young RH
Pathology; 2018 Jan; 50(1):5-15. PubMed ID: 29132723
[TBL] [Abstract][Full Text] [Related]
79. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases.
Oliva E; Alvarez T; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):143-56. PubMed ID: 15644771
[TBL] [Abstract][Full Text] [Related]
80. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
